CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) (USD $) In Thousands, unless otherwise specified	3 Months Ended
	Mar. 31, 2012	Mar. 31, 2011
Operating activities
Net income (loss)	$ 5,327	$ (7,790)
Adjustments to reconcile net income (loss) to cash provided by (used in) operating activities:
Depreciation and amortization	17,990	9,084
Depreciation and amortization - discontinued operations	414	15,816
Amortization of above market leases	1,126	39
Amortization of below market leases - discontinued operations	(32)	(339)
Amortization of loan costs	537	479
Amortization of mortgage loan discount	0	(197)
Share-based compensation expense	157	407
Deferred income tax benefit	(245)	0
Operating distributions from unconsolidated joint ventures	0	465
Gain on sale of real estate investments - discontinued operations	(5,575)	0
Equity in earnings of unconsolidated joint ventures	0	(41)
Equity in loss of unconsolidated joint ventures - discontinued operations	20	6
Change in fair value of contingent consideration	216	0
Increase in deferred leasing costs	(1,792)	(3,579)
Change in receivables and other assets	8,468	(1,362)
Change in accounts payable and other liabilities	(11,045)	(18,135)
Net cash provided by (used in) operating activities	15,566	(5,147)
Investing activities
Distributions from unconsolidated joint ventures	120	135
Investment in real estate	(128,873)	(89,401)
Proceeds from sale of real estate	110,754	0
Improvements to real estate	(7,911)	(5,915)
Net cash used in investing activities	(25,910)	(95,181)
Financing activities
Principal payments on mortgage notes payable	(18,033)	(3,393)
Proceeds from mortgage notes payable	73,500	19,250
Proceeds from bank borrowings	30,126	89,386
Payments on bank borrowings	(114,448)	(33,644)
Debt financing costs	(2,169)	(3,294)
Purchase of Company stock	(113)	(299)
Dividends paid on common stock	(1,657)	(1,655)
Dividends paid on preferred stock	(2,711)	(2,187)
Contributions from noncontrolling interest partners	2,731	96,285
Distributions to noncontrolling interest partners	(566)	(5,631)
Issuance costs for shelf registration	(10)	0
Net cash (used in) provided by financing activities	(33,350)	154,818
Change in cash and cash equivalents	(43,694)	54,490
Cash and cash equivalents at beginning of period	75,183	19,670
Cash and cash equivalents at end of period	$ 31,489	$ 74,160